Domov › Rak pljuč › Pennsylvania › Reading
Klinične študije za Rak pljuč v Reading, PA
11 študij za Rak pljuč išče udeležence na lokacijah v Reading in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Reading Hospital, West Reading · 1 mi stran
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Penn State Health Saint Joseph Medical Center, Reading
- Reading Hospital, West Reading · 1 mi stran
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Vključevanje udeležencevFaza 3
- Reading Hospital, West Reading · 1 mi stran
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Vključevanje udeležencevFaza 3
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Vključevanje udeležencevFaza 3
- Reading Hospital, West Reading · 1 mi stran
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi stran
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Reading Hospital, West Reading · 1 mi stran
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Ephrata Cancer Center, Ephrata · 17 mi stran
- Sechler Family Cancer Center, Lebanon · 26 mi stran
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Vključevanje udeležencevOpazovalna študija
- US Digestive Health at Wyomissing, Wyomissing · 2 mi stran
Študije za Rak pljuč v drugih mestih
- Houston, TX78 študij
- Boston, MA62 študij
- New York City, NY60 študij
- Los Angeles, CA45 študij
- Washington, DC41 študij
- Arlington, VA41 študij
- Chicago, IL41 študij
- Nashville, TN40 študij
- Baltimore, MD40 študij
- St. Louis, MO39 študij
- Columbus, OH37 študij
- Philadelphia, PA36 študij
Druge študije v Reading
- Nemalicelični pljučni rak9 študij
- Akutna mieločna levkemija5 študij
- Rak dojke5 študij
- Motnje prekomerne zaspanosti5 študij
- Rak prostate4 študij
- Rak (vse vrste)4 študij
- Kolorektalni rak3 študij
- Narkolepsija3 študij
- Motnje spanja3 študij
- Utrujenost3 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.